Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Analytica Chimica Acta|August 17, 2017
Advanced nanotechnologies in avian influenza: Current status and future trends - A reviewAmitava Moulick, Lukas Richtera, Vedran Milosavljevic, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|December 24, 2010
Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective studyMohammed A Al-Ghazo, Ibrahim F Ghalayini, Rami S Al-Azab, et al.
Frontiers in Microbiology|September 28, 2020
Characterization and <i>in vitro</i> Analysis of Probiotic-Derived Peptides Against Multi Drug Resistance Bacterial InfectionsAninda Mazumdar, Yazan Haddad, Vishma Pratap Sur, et al.
Pharmacological Research|June 23, 2026
Artesunate as an Emerging Anticancer Modality: Insights and AdvancesFrantisek Petrlak, Vendula Jemelikova, Anna Hanzlikova, et al.
Plos One|October 12, 2016
The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer TherapyVedran Milosavljevic, Yazan Haddad, Miguel Angel Merlos Rodrigo, et al.
Journal of Clinical Medicine Research|August 4, 2011
Clinical comparison of conventional testicular sperm extraction and microdissection techniques for non-obstructive azoospermiaIbrahim Fathi Ghalayini, Mohammed A Al-Ghazo, Osama Bani Hani, et al.
Plos One|September 18, 2018
Correction: The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer TherapyVedran Milosavljevic, Yazan Haddad, Miguel Angel Merlos Rodrigo, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 3, 2020
Metallothionein isoforms as double agents - Their roles in carcinogenesis, cancer progression and chemoresistanceMiguel Angel Merlos Rodrigo, Ana Maria Jimenez Jimemez, Yazan Haddad, et al.
Plos One|June 24, 2022
Correction: The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer TherapyVedran Milosavljevic, Yazan Haddad, Miguel Angel Merlos Rodrigo, et al.
Cancer Epidemiology|June 15, 2010
FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian populationKhaldon Bodoor, Abdulhameed Ghabkari, Ziad Jaradat, et al.
Pageof 5